05 June 2024 | Wednesday | News
Image Source : Public Domain
AmpleLogic, a leading provider of GAMP solutions, announces the launch of its revolutionary Application Platform as a Service (aPaaS) designed specifically for the life sciences sector. This cutting-edge platform leverages low-code/no-code technology to accelerate digitization in life sciences industry while enhancing operational efficiency and ensuring compliance with regulatory standards from USFDA, MHRA, EMEA, ISO, and GAMP guidelines.
AmpleLogic's aPaaS platform offers a unique Build Your Own Application (BYOA) feature, enabling companies to quickly respond to emerging regulatory requirements and operational challenges. They can customize an application using the platform specific to their business use case.
Additionally, AmpleLogic also offers a comprehensive suite of 14 ready-to-use, pre-validated applications designed for regulated industries such as pharmaceuticals manufacturing, biotechnology, medical devices, gene therapy, beauty & cosmetics, food & beverages, and more. These include:
"We are excited to launch our new aPaaS platform made for the life sciences industry, designed to streamline operations and ensure compliance," said Mr. Manne V. Chowdhary, CEO & MD of AmpleLogic. "Our platform leverages the latest technologies to provide scalable and flexible solutions that meet the unique needs of our clients in the life sciences sector. With over 100 happy clients spanning 14 years of operations in this field, this is one of AmpleLogic's many endeavors and a step forward in our mission to deliver innovative and effective software solutions."
AmpleLogic also integrates AI and ML for enhanced solutions, offering predictive analysis and automated SOP-based questionnaire generation. Their Learning Management System uses these technologies for targeted training, ensuring compliance and workforce readiness.
Most Read
Bio Jobs
News
Editor Picks